Ewopharma AG Announces Exclusive Distribution Agreement for Cardiovascular Solutions in Bulgaria
Effective June 1, 2024, Ewopharma AG has the exclusive licence to distribute Translumina’s drug-eluting stents (DES) and…
Ewopharma AG
AllergyCare AG Becomes Part Of Ewopharma Group
Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to ann…
Ewopharma and CStone enter into a Strategic Partnership for Sugemalimab in Central Eastern Europe and Switzerland
Ewopharma announces today that it has entered into a strategic commercial collaboration with CStone Pharmaceuticals (“CS…
Neomed s.r.o. becomes part of Ewopharma Group
Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to ann…
Ewopharma and Eisai Announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)
Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pha…
Otsuka și Ewopharma AG se alătură luptei împotriva tuberculozei, în România, prin lansarea medicamentului orfan dezvoltat de Otsuka - Deltyba® (delamanid) pentru tuberculoza plurirezistentă la medicamente
Tuberculoza (TBC) este principala cauză de deces provocat de o boală infecțioasă, la nivel global.[1] Otsuka Pharmaceuti…
Ewopharma and Vianex announce collaboration to distribute the essential antibiotic Amikacin in Switzerland
Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewo…
Ewopharma and Vianex announce collaboration to distribute the essential antibiotic Amikacin in Switzerland
Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewo…
Your one-stop-shop to commercialize your product successfully
Getting 60 years in 2019 Ewopharma decided for a new appearance. The adjustments that have been made are a cautious and…
